Page last updated: 2024-10-25

deferoxamine and Carcinoma, Non-Small Cell Lung

deferoxamine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Madajewski, B1
Chen, F1
Yoo, B1
Turker, MZ1
Ma, K1
Zhang, L1
Chen, PM1
Juthani, R1
Aragon-Sanabria, V1
Gonen, M1
Rudin, CM1
Wiesner, U1
Bradbury, MS1
Brennan, C1
Suchaoin, W1
Chanvorachote, P1

Other Studies

2 other studies available for deferoxamine and Carcinoma, Non-Small Cell Lung

ArticleYear
Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 10-15, Volume: 26, Issue:20

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Drug De

2020
Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells.
    Anticancer research, 2012, Volume: 32, Issue:2

    Topics: Antioxidants; Carcinoma, Non-Small-Cell Lung; Caveolin 1; Cell Death; Cell Line, Tumor; Deferoxamine

2012